The relevance of CD38 in CLL (other than its being a prognostic marker) has been demonstrated by several studies highlighting its role as both an independent signal transducer and associated factor in a variety of signaling pathways including CXCR4 and BCR signaling. Here, BCR is linked to B-cell chronic lymphocytic leukemia.